Controlled human malaria infection with Plasmodium falciparum demonstrates impact of naturally acquired immunity on virulence gene expression
Year: 2019
Type: article
Study design: Clinical Trial
Abstract: The pathogenesis of Plasmodium falciparum malaria is linked to the variant surface antigen PfEMP1, which mediates tethering of infected erythrocytes to the host endothelium and is encoded by approximately 60 var genes per parasite genome. Repeated episodes of malaria infection result in the gradual acquisition of protective antibodies against PfEMP1 variants. The antibody repertoire is believed to provide a selective pressure driving the clonal expansion of parasites expressing unrecognized PfEMP1 variants, however, due to the lack of experimental in vivo models there is only limited experimental evidence in support of this concept. To get insight into the impact of naturally acquired immunity on the expressed var gene repertoire early during infection we performed controlled human malaria infections of 20 adult African volunteers with life-long malaria exposure using aseptic, purified, cryopreserved P. falciparum sporozoites (Sanaria PfSPZ Challenge) and correlated serological data with var gene expression patterns from ex vivo parasites. Among the 10 African volunteers who developed patent infections, individuals with low antibody levels showed a steep rise in parasitemia accompanied by broad activation of multiple, predominantly subtelomeric var genes, similar to what we previously observed in naïve volunteers. In contrast, individuals with intermediate antibody levels developed asymptomatic infections and the ex vivo parasite populations expressed only few var gene variants, indicative of clonal selection. Importantly, in contrast to parasites from naïve volunteers, expression of var genes coding for endothelial protein C receptor (EPCR)-binding PfEMP1 that are associated with severe childhood malaria was rarely detected in semi-immune adult African volunteers. Moreover, we followed var gene expression for up to six parasite replication cycles and demonstrated for the first time in vivo a shift in the dominant var gene variant. In conclusion, our data suggest that P. falciparum activates multiple subtelomeric var genes at the onset of blood stage infection facilitating rapid expansion of parasite clones which express PfEMP1 variants unrecognized by the host's immune system, thus promoting overall parasite survival in the face of host immunity.
Source: PLoS Pathogens
Institutions: German Center for Infection Research, Bernhard Nocht Institute for Tropical Medicine, Universitätsklinikum Tübingen, University of Copenhagen, The University of Melbourne, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsklinikum Erlangen, Sanaria, Centre de Recherche Médicales de Lambaréné
Language: English
Topic: Malaria Research and Control
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,350
Funders: Deutsches Zentrum für Infektionsforschung, Deutsche Forschungsgemeinschaft, Bundesministerium für Bildung und Forschung, Novo Nordisk, Danmarks Frie Forskningsfond, Bundesministerium für Forschung und Technologie, Novo Nordisk Fonden, National Institutes of Health, National Institute of Allergy and Infectious Diseases, European and Developing Countries Clinical Trials Partnership
Awards: Universal Attenuated Sporozoite Vaccine and Challenge System, G1881230665, G2310371553, G2904193375, Plasmodium Falciparum Whole Sporozoite Malaria Vaccine, G3349051739, G3391023465, G4026550914, G4648310661, G4931116420, G5494700516, G5582358084, G5991770078, G6009940204, G6706544399, G7585759177, G8627103573, G9000334340
OpenAlex ID: W2962225605
